Posts Tagged 'YMI'

Since Canaccord Genuity initiated coverage with a “buy” rating and $4.00 price target, the penny stock of YM BioSciences Inc. (AMEX: YMI), has dropped -9.33%. Why the shares of YMI are so undervalued when you look deep into their product line is puzzling. Shares of YMI closed up 4.17% at $1.75 on lighter than average volume in the last trading session.

There ...